Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
- Resource Type
- article
- Source
- PLoS Medicine, Vol 21, Iss 5 (2024)
- Subject
Medicine - Language
- English
- ISSN
- 1549-1277
1549-1676